Table 3.
Number of participants in the different nephrotoxicity classes
| Nephrotoxicity | Number of participants | Total n (%) |
|
|---|---|---|---|
| No diabetes n (%) |
Diabetes n (%) |
||
| A | 162 (92.05) | 172 (91.98) | 334 (92.01) |
| B | 12 (6.82) | 13 (6.95) | 25 (6.89) |
| C | 1 (0.57) | 2 (1.07) | 3 (0.83) |
| D | 1 (0.57) | 0 (0.00) | 1 (0.28) |
| Total | 176 (100) | 187 (100) | 363 (100) |
A = No need for dosage modification; B = The information is not available or the recommendation is estimated based on the pharmacokinetic characteristics of the substance; C = Modification of the dose or dosage interval is needed; D = The use should be avoided